Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2026 FYStats. 
Home
Equities
LIMN
Fundamentals

Liminatus Pharma, Inc.

LIMN

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

1.34M
▼-566.37k▼-29.67%
3 Months Change

Liabilities

2.99M
▼-7.73M▼-72.12%
3 Months Change

Free Cash Flow

0.00
0.000.00%
-

Revenue/Cost Of Revenue

Loading...

Net Profit/Loss

Loading...

Assets/Liabilities

Loading...

Cash Flows

Loading...

Earnings Per Share

Loading...

Outstanding Shares

Loading...

Recent Quarterly and Annual Filings

2026-03-04
Form 8-K
ID: 0001104659-26-023467
2026-02-18
Form 8-K
ID: 0001104659-26-017134
2026-02-09
Form 8-K
ID: 0001104659-26-012016
2026-01-26
Form 8-K
ID: 0001104659-26-006619
2025-11-25
Form 8-K
ID: 0001104659-25-116049
2025-11-14
Form 10-Q
ID: 0001104659-25-111651
2025-10-06
Form 10-Q
ID: 0001104659-25-096872
2025-08-25
Form 8-K
ID: 0001104659-25-082579
2025-08-14
Form 8-K
ID: 0001104659-25-078577
2025-07-17
Form 8-K
ID: 0001104659-25-068670